Sign in
CompletedNo phase

Sleep Without Insomnia or The Use of Chronic Hypnotics

Key facts

Who runs it
University of California, Los Angeles
Where
Los Angeles, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
188 people enrolled
Started
11 Dec 2018
Ended
27 Nov 2023
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Program A
  • Program B
Record updated
7 April 2026

Who can take part

Age
55 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (17)Hide the full registry criteria

Who can take part

  • Age >= 55 years
  • Use of lorazepam, alprazolam, temazepam,and/or zolpidem for current or prior insomnia symptoms 2 or more nights per week for at least 3 months
  • Current or prior insomnia symptoms
  • Available to attend weekly in-person sessions over 9 weeks

Who cannot take part

  • High baseline risk of complicated withdrawal;benzodiazepine intoxication or current or past symptoms of complicated benzodiazepine/alcohol withdrawal (e.g.,seizure, delirium at baseline (prior to taper))
  • Unable to keep study medications in secure location
  • Medically/psychiatrically unstable (e.g., planned major surgery during the study period;psychosis, suicidal, active alcohol/substance abuse based on history and medical records)
  • Seizure disorder
  • Evidence of prescription fraud (e.g., multiple prescriptions for same drug filled at multiple pharmacies during overlapping time periods, diversion); Discontinuation of hypnotic not appropriate:; •Study-targeted hypnotic used to treat another clinical condition (e.g., panic disorder); Poor candidate for cognitive behavioral therapy for insomnia:
  • Presence of bipolar disorder
  • Cognitive impairment (e.g., Mini-Mental State Examination < 24)
  • Sleep/wake difficulty is better explained by another sleep disorder such as restless legs syndrome, narcolepsy, insufficient sleep syndrome, or circadian rhythm sleep-wake disorders
  • High risk for complications in outpatient hypnotic discontinuation program:
  • Supratherapeutic or high baseline hypnotic dose (> diazepam-equivalent of 8 mg/night)
  • Polydrug use (e.g., chronic high dose opioids)
  • Untreated sleep-disordered breathing (respiratory event index >= 15 and < 30 plus excessive daytime sleepiness, or REI >=30)
  • Unstable housing situation

Where in United States

  • University of California, Los AngelesLos Angeles, United States
  • VA Greater Los AngelesLos Angeles, United States

About the trial

What the trial wants to find out

Sleeping medications, called hypnotics, are often prescribed for insomnia and are associated with adverse health outcomes in older adults. Response rates to hypnotic discontinuation programs are often inadequate, and many patients eventually resume use of hypnotics, suggesting that other mechanisms need to be targeted to achieve and sustain high rates of non-use. Current programs focus on the tapering of hypnotics and/or the treatment of insomnia symptoms. These programs employ strategies such as supervised gradual taper, cognitive behavioral therapy targeting hypnotic withdrawal, and/or cognitive behavioral therapy for insomnia. Evidence suggests that another mechanism involving "placebo" effects may be a viable target for achieving and sustaining higher discontinuation rates. Cognitive expectancies play a key role in producing placebo effects, which are characterized as real improvements in sleep arising from psychosocial aspects of treatment rather than drug effects alone. In this study, investigators are comparing two programs for discontinuing hypnotic medications-a program that addresses placebo effects associated with hypnotic use and a program that does not address these effects.

The 2 groups in the trial

  • Program ATreatment being tested

    cognitive behavioral therapy type A plus medications in packaging type A

  • Program BExisting treatment, for comparison

    cognitive behavioral therapy type B plus medications in packaging type B

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Novel Mechanism for Helping Older Adults Discontinue Use of Sleeping Pills
Publications
Record updated
7 April 2026